Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical development of ...

On Tuesday, IGM Biosciences Inc. (NASDAQ:IGMS) announced a strategic pivot and pipeline transformation to accelerate and ...

Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical development of imvotamab in rheumatoid arthritis and systemic lupus erythematosus - - Mary Beth ...

IGM Biosciences ended last year laying off staff and streamlining its cancer pipeline. | IGM Biosciences ended last year ...

Fintel reports that on October 1, 2024, Truist Securities downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from ...

Fintel reports that on October 1, 2024, JP Morgan downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Neutral ...

Wedbush analyst Robert Driscoll maintained a Buy rating on IGM Biosciences (IGMS – Research Report) today and set a price target of ...

Analyst Michael Ulz of Morgan Stanley maintained a Hold rating on IGM Biosciences (IGMS – Research Report), retaining the price target of ...

On Tuesday, IGM Biosciences Inc. (NASDAQ:IGMS) announced a strategic pivot and pipeline transformation to accelerate and deepen its leadership in developing T cell-engaging IgM antibodies for ...

IGM Biosciences Inc.'s stock tumbled 14% Tuesday, as analysts weighed in with dismay on the company's pivot away from oncology to a focus on autoimmune diseases, with at least two opting to lower ...

Laboratory tests for Dengue diagnosis used are Dengue NS1 antigen detection, Dengue IgM, Dengue IgG antibody, Dengue PCR, CBC, low platelet count, and immature platelet fraction. Chikungunya ...